BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs4950928
,
NEUROG3
,
T cell differentiation
,
Arthritis
,
Adipose tissue
,
Autoimmunity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
proto oncogene proteins c- jun
Summary
General Info
Curated Studies
Most Correlated Studies
Induced pluripotent stem cells by direct delivery of Oct4, Sox2, Klf4,and c-Myc proteins
Breast cancer MCF7 cells overexpressing ROR2 with or without stimulation by its ligand WNT5A
LNCaP cell line expression with siRNA knockdown of COP1, ETV1, and/or c-JUN
Lens expression profile of DBL oncogene transgenic mice
Explore Curated Studies Results
Literature
Most Relevant Literature
MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression.
Stk40 deletion elevates c-JUN protein level and impairs mesoderm differentiation.
Expression of c-jun protein after experimental rat brain concussion].
The ubiquitin-specific protease USP6 regulates the stability of the c-Jun protein.
Anthrax lethal toxin rapidly reduces c-Jun levels by inhibiting c-Jun gene transcription and promoti…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Effect of Different Therapeutic Strategies on Regulatory T Cells in Kidney Transplantation
A Study Evaluating the Combination of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or Infus…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ